These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 43182)

  • 1. Dose dependent disposition of [14C]-ICI 89,406 in the male rat: is this due to a capacity limited excretory pathway for the drug into bile? [proceedings].
    Barnfield DJ; Bourne GR; Lowery C; Moss SR
    Br J Pharmacol; 1979 Jul; 66(3):492P. PubMed ID: 43182
    [No Abstract]   [Full Text] [Related]  

  • 2. On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent.
    Haustein KO; Fritzsche K
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):392-5. PubMed ID: 6117520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W; Wenzel A
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract]   [Full Text] [Related]  

  • 4. [The metabolism of 1-tertiary-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker agent. II. Blood level, distribution, and structure of its metabolites in bile (author's transl)].
    Honma S; Kanbekawa A
    Yakugaku Zasshi; 1975 Jun; 95(6):680-9. PubMed ID: 241825
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings].
    Bianchetti G; Brancaccio D; Forette F; Henry JF; Hervy MP; Ganansia J; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Mar; 9(3):299P. PubMed ID: 6102472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro].
    Honma S; Ito T; Matsuki Y
    Yakugaku Zasshi; 1986 May; 106(5):406-13. PubMed ID: 2876088
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition of [14C]nadolol in dogs with reversible renal impairment induced by uranyl nitrate.
    Singhvi SM; Heald AF; Murphy BF; DiFazio LT; Schreiber EC; Poutsiaka JW
    Toxicol Appl Pharmacol; 1978 Jan; 43(1):99-109. PubMed ID: 24287
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolism of ICI 118,587, a partial agonist of beta 1-adrenoceptors, in mice, rats, rabbits, dogs, and humans.
    Marten TR; Bourne GR; Miles GS; Shuker B; Rankine HD; Dutka VN
    Drug Metab Dispos; 1984; 12(5):652-60. PubMed ID: 6149919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution of exaprolol in rat.
    Faberová V; Trnovec T; Zemánek M; Bezek S; Durisová M; Tomcíková O
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):11-3. PubMed ID: 2863149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
    Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
    Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic studies of ethylenediamine derivatives: absorption, tissue distribution and elimination of IF-ROM-203-14C compound.
    Nowicka A; Szukalski B; Prussak T; Jahn W
    Mater Med Pol; 1977; 9(3):239-43. PubMed ID: 926839
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: The hypoglycaemic action of ICI 66082 (4-(2-hydroxy-3-isopropyl-aminopropoxy) phenyl acetamide) in the rat.
    Furman BL; Tayo FM
    Br J Pharmacol; 1974 Sep; 52(1):143P. PubMed ID: 4155984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of 1-(4'-oxyphenyl)-2-(3'-phenyl-thiopropyl-amino) propane-1-01 hydrochloride (Istiod) in the rat].
    Giordano L; Luppino E; Chianese G; Ariello B; Ievoli C
    Arch Sci Med (Torino); 1980; 137(2):247-52. PubMed ID: 7224846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys.
    Waller AR; Chasseaud LF; Bonn R; Taylor T; Darragh A; Girkin R; Down WH; Doyle E
    Drug Metab Dispos; 1982; 10(1):51-4. PubMed ID: 6124383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol.
    Kabuto S; Kimata H; Yonemitsu M; Koide T; Nakao H; Suzuki J
    Arzneimittelforschung; 1985; 35(11):1674-9. PubMed ID: 3937533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S
    Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560
    [No Abstract]   [Full Text] [Related]  

  • 17. The spectrofluorimetric estimation and buccal absorption of SL 75212, a novel beta-adrenoceptor antagonist [proceedings].
    Davis BJ; Turner P
    Br J Clin Pharmacol; 1979 Oct; 8(4):405P. PubMed ID: 41558
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic studies on CS-359, a new beta-adrenergic blocking agent. I. Isolation and identification of the urinary metabolites of CS-359.
    Hayashi R; Okada M; Nakazawa T; Tanaka Y; Shimoji Y
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1173-83. PubMed ID: 241498
    [No Abstract]   [Full Text] [Related]  

  • 19. The disposition of primaquine in the isolated perfused rat liver. Effect of dose size.
    Ward SA; Mihaly GW; Nicholl DD; Edwards G; Breckenridge AM
    Drug Metab Dispos; 1985; 13(4):425-9. PubMed ID: 2863105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology and clinical pharmacokinetics of nadolol].
    Lazowski J; Wegrzyn B; Lypka A
    Pol Tyg Lek; 1981 Sep; 36(39):1521-4. PubMed ID: 6121320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.